Post Categories
Challenging the Inhaled Allergen Challenge
May 9, 2019
Presently, the QPS Respiratory Team is making progress on a large data-intensive, 2-centre allergen challenge study in eosinophilic allergic asthma testing an innovative new…
QPS has a Strong Competency in Alzheimer Research
May 9, 2019
The results of a research collaboration between the neuroscience group of QPS Netherlands B.V. and Professor Peter Paul de Deyn and coworkers of the…
QPS will exhibit at the World Vaccine Congress
April 15, 2019
QPS will exhibit at the World Vaccine Congress, April 15-17 in Washington, DC. Please stop by our booth #600 to learn more about QPS’…
BREXIT IMPACT: More Questions Than Answers
March 30, 2019
Later this month the United Kingdom (UK) is expected to achieve independence from the European Union (EU) based on a referendum that was passed…
QPS is exhibiting at the 13th Annual WRIB Meeting
March 27, 2019
QPS is exhibiting at the 13th Annual WRIB Meeting, April 1-4 in New Orleans, LA. If you are attending, please visit us at booth…
QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany.
October 4, 2018
QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany. Please stop by our Booth #5 to learn…
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease
March 26, 2019
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease, March 26-31 in Lisbon, Portugal. Please stop by our booth #28…
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference
March 26, 2019
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the…
Spreading Early Clinical Knowledge
October 20, 2017
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific…
Translational Medicine Now Bigger and Better at QPS
July 14, 2017
Goodbye boutique CRO, hello large study BIG PLAYER! For a long time, you’ve known us as THE high quality outfit that can stabilize difficult…
QPS’ Paul Lehman to Speak at Transdermal & Intradermal Drug Delivery Conference
June 12, 2017
The 2017 Transdermal & Intradermal Drug Delivery Systems conference covering Advanced Design, Development & Delivery of Skin-Mediated Therapies and Vaccines is coming up on…
QPS Tapped for Two New FIH Studies
May 5, 2017
Two companies have just selected QPS Netherlands to conduct their First-in-Human studies. Acticor Biotech, a Paris-based biotechnology company focused on the treatment of acute…
More Simple Rabies Test Could Reduce Rabies Deaths
September 21, 2022
According to the Centers for Disease Control and Prevention (CDC), the rabies virus leads to an estimated 59,000 human deaths globally each year. This…
It Took Time, But Ionis Made Antisense Therapy Make Sense
September 19, 2022
Although antisense therapy — using antisense oligonucleotides (ASOs) to control protein function — has generated controversy and skepticism over the years, it is now…
Holding Out Hope for a Deal on Long-Lasting HIV Prevention Drug
September 11, 2022
Although a new injectable anti-HIV drug, cabotegravir, could be instrumental in drastically reducing the spread of disease, its price tag may render the drug…
How Ancient Wolves Evolved into Man’s Best Friend
August 29, 2022
If you compare a pack of fearsome ancient wolves with a pack of modern-day chihuahuas, it’s clear that domesticated dogs have evolved almost beyond…
Could Bear Serum Help the Bedridden?
August 22, 2022
Prolonged periods of rest are essential for the sick and those recovering from surgery, but bed rest takes its toll on human bodies. Animal…
Study Finds Norovirus Could Spread Through Saliva
August 17, 2022
Norovirus is the most common cause of acute gastroenteritis, causing an estimated 685 million cases each year. The virus can lead to severe illness…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
